Verbatim response from Claude
This is a rapidly changing landscape, so I want to be straightforward with you:
Current Situation (as of early 2025)
The FDA declared the semaglutide shortage over, which triggered restrictions on compounded versions. However, several platforms were still navigating this:
Platforms that were offering compounded GLP-1s or alternatives:
- Hims & Hers - was offering compounded semaglutide but faced pressure to stop
- Henry - was transitioning policies
- Mochi Health - focused on personalized obesity treatment
- LifeMD - offered various weight loss programs
Important Caveats
I'd strongly encourage caution here because:
- The situation changes week to week with FDA enforcement
- Compounded semaglutide legality is genuinely contested in courts right now
- Quality control of compounded versions varies significantly
- Some providers are pivoting to tirzepatide (Mounjaro/Zepbound) compounded versions, which may still be in shortage status
My Honest Recommendation
- Check directly with any platform before signing up - policies change fast
- Ask specifically about FDA compliance and compounding pharmacy accreditation
- Consider whether brand-name options with manufacturer coupons might work for you
Would you like help thinking through what questions to ask these services?